What is Actos?
Actos Warnings and Alerts
Actos Smoking Gun
Actos Lawsuits
Actos Whistleblower Lawsuit
Our Actos Attorneys
Our Case Results
Contact an Actos Lawyer

Bladder Cancer Information
Bladder Cancer Types
Bladder Cancer Symptoms
Bladder Cancer Treatment
Bladder Cancer Causes

Studies Link Actos to
Bladder Cancer


Medical Terms Dictionary


Report Adverse Side Effects
to FDA MedWatch

Report Adverse Side Effects
to Rxisk.org


Watch Our Video

Tell Us What
Happened to You

*Confirm Email
*State
This field must be blank
*Describe your symptoms
Recent News

Actos Bladder Cancer Lawsuit Verdict Reinstated
July 16, 2015

Takeda Pharmaceuticals Continues Court Ordered Search for Missing Files in Actos Bladder Cancer Litigation
October 17, 2014
Takeda and Eli Lilly Sued Over Actos Bladder Cancer Claims
September 5, 2014

We are no longer accepting Actos cases.

Actos Bladder Cancer Causes

Although the exact cause of bladder cancer is unknown, it has been associated with a number of potential risk factors including chemical exposure and smoking. Bladder cancer has also been linked to the prolonged use of the diabetes drug Actos. The Food and Drug Administration (FDA) released a safety announcement in 2011 warning that, “compared to never being exposed to pioglitazone, a duration of pioglitazone therapy longer than 12 months was associated with a 40% increase in risk.”

If you have taken or are taking the diabetes drug Actos and have been diagnosed with bladder cancer, you may be entitled to compensation.


If you have taken Actos and have since been diagnosed with bladder cancer, you may be entitled to compensation.

Click here for a free case evaluation or call
800-827-0087.



The law firm of Baum, Hedlund, Aristei & Goldman has extensive experience in litigating personal injury, wrongful death and consumer class action cases against major drug companies for more than 20 years. Baum Hedlund has successfully represented clients harmed by prescription medications in over 4,000 individual cases, in addition to representing consumers in multiple pharmaceutical class actions. The firm has offices in Los Angeles, Philadelphia, and Washington, D.C., and is listed in the Bar Register of Preeminent Lawyers.